Guerbet SA
EPA:GBT.PA
29.7 (EUR) • At close November 12, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Guerbet SA |
Symbool | GBT.PA |
Munteenheid | EUR |
Prijs | 29.7 |
Beurswaarde | 374,486,647 |
Dividendpercentage | 1.35% |
52-weken bereik | 17.02 - 40.25 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. David Hale |
Website | https://www.guerbet.com |
An error occurred while fetching data.
Over Guerbet SA
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)